Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

INVO Bioscience Inc INVO

INVO Bioscience, Inc. is a healthcare services fertility company. The Company is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. The Company’s flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its technique, designated as IVC, provides patients a more connected and intimate experience at a more affordable cost in comparison to in vitro fertilization (IVF), the other advanced ART treatment. Its commercialization strategy is focused on the opening of INVO Centers offering the INVOcell and IVC procedure and the acquisition of existing IVF clinics. The Company operates three INVO Centers in North America.


NDAQ:INVO - Post by User

Post by whytestockson Apr 17, 2024 1:00pm
23 Views
Post# 35994090

Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge | Benzi

Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge | Benzi
News; $INVO Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge | BenzingaU.S. stocks traded lower midway through trading, with the Dow Jones index falling around 100 points on Wednesday.The Dow traded down 0.32% to 37,6...INVO - Nasdaq Down Over 1%; Sage Therapeutics Shares Plunge | Benzinga


<< Previous
Bullboard Posts
Next >>